RSC Advances,
Journal Year:
2023,
Volume and Issue:
13(50), P. 35500 - 35524
Published: Jan. 1, 2023
The
pandemic
caused
by
the
coronavirus
SARS-CoV-2
led
to
a
global
crisis
in
world
healthcare
system.
Despite
some
progress
creation
of
antiviral
vaccines
and
mass
vaccination
population,
number
patients
continues
grow
because
spread
new
mutations.
There
is
an
urgent
need
for
direct-acting
drugs
capable
suppressing
or
stopping
main
mechanisms
reproduction
SARS-CoV-2.
Several
studies
have
shown
that
successful
replication
virus
cell
requires
proteolytic
cleavage
protein
structures
virus.
Two
proteases
are
crucial
replicating
other
coronaviruses:
protease
(Mpro)
papain-like
(PLpro).
In
this
review,
we
summarize
essential
viral
proteins
required
its
life
cycle
as
targets
chemotherapy
infection
provide
critical
summary
development
against
COVID-19
from
drug
repurposing
strategy
up
molecular
design
novel
covalent
non-covalent
agents
inhibiting
replication.
We
overview
choice
Mpro
PLpro
promising
pharmacological
impact
on
cycle.
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(2), P. 232 - 232
Published: Feb. 9, 2024
Stilbenes
are
phytoalexins,
and
their
biosynthesis
can
occur
through
a
natural
route
(shikimate
precursor)
or
an
alternative
(in
microorganism
cultures).
The
latter
is
metabolic
engineering
strategy
to
enhance
production
due
stilbenes
recognized
pharmacological
medicinal
potential.
It
believed
that
in
the
human
body,
these
potential
activities
be
modulated
by
regulation
of
nuclear
factor
erythroid
derived
2
(Nrf2),
which
increases
expression
antioxidant
enzymes.
Given
this,
our
review
aims
critically
analyze
evidence
regarding
E-stilbenes
metabolism
Nrf2
activation
pathway,
with
emphasis
on
inflammatory
oxidative
stress
aspects
related
pathophysiology
chronic
diseases.
In
this
comprehensive
literature
review,
it
observed
despite
broad
number
stilbenes,
those
most
frequently
explored
clinical
trials
preclinical
studies
vitro
vivo)
were
resveratrol,
piceatannol,
pterostilbene,
polydatin,
stilbestrol,
pinosylvin.
some
cases,
depending
dose/concentration
chemical
nature
stilbene,
was
possible
identify
pathway.
Furthermore,
use
experimental
models
presented
challenge
comparing
results.
view
above,
suggested
have
relationship
whether
directly
indirectly,
different
biological
pathways,
diseases
conditions
mainly
inflammation
stress.
Biomedicines,
Journal Year:
2021,
Volume and Issue:
9(6), P. 689 - 689
Published: June 18, 2021
As
a
public
health
emergency
of
international
concern,
the
highly
contagious
coronavirus
disease
2019
(COVID-19)
pandemic
has
been
identified
as
severe
threat
to
lives
billions
individuals.
Lung
cancer,
malignant
tumor
with
highest
mortality
rate,
brought
significant
challenges
both
human
and
economic
development.
Natural
products
may
play
pivotal
role
in
treating
lung
diseases.
We
reviewed
published
studies
relating
natural
products,
used
alone
or
combination
US
Food
Drug
Administration-approved
drugs,
active
against
acute
respiratory
syndrome
2
(SARS-CoV-2)
cancer
from
1
January
2020
31
May
2021.
A
wide
range
can
be
considered
promising
anti-COVID-19
anti-lung
agents
have
gained
widespread
attention,
including
monotherapy
for
treatment
SARS-CoV-2
(ginkgolic
acid,
shiraiachrome
A,
resveratrol,
baicalein)
(daurisoline,
graveospene
deguelin,
erianin)
FDA-approved
anti-SARS-CoV-2
(cepharanthine
plus
nelfinavir,
linoleic
acid
remdesivir)
(curcumin
cisplatin,
celastrol
gefitinib).
demonstrated
potential
value
assistance
nanotechnology,
drug
therapies,
codrug
strategy,
this
“natural
remedy”
could
serve
starting
point
further
development
these
Acta Pharmaceutica Sinica B,
Journal Year:
2022,
Volume and Issue:
12(11), P. 4154 - 4164
Published: Aug. 9, 2022
It
is
an
urgent
demand
worldwide
to
control
the
coronavirus
disease
2019
(COVID-19)
pandemic
caused
by
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
virus.
The
3-chymotrypsin-like
protease
(3CLpro)
and
papain-like
(PLpro)
are
key
targets
discover
SARS-CoV-2
inhibitors.
After
screening
12
Chinese
herbal
medicines
125
compounds
from
licorice,
we
found
that
a
popular
natural
product
schaftoside
inhibited
3CLpro
PLpro
with
IC50
values
of
1.73
±
0.22
3.91
0.19
μmol/L,
respectively,
virus
in
Vero
E6
cells
EC50
11.83
3.23
μmol/L.
Hydrogen–deuterium
exchange
mass
spectrometry
analysis,
quantum
mechanics/molecular
mechanics
calculations,
together
site-directed
mutagenesis
indicated
antiviral
activities
were
related
non-covalent
interactions
H41,
G143
R188
3CLpro,
K157,
E167
A246
PLpro.
Moreover,
proteomics
analysis
cytokine
assay
revealed
also
regulated
immune
response
inflammation
host
cells.
anti-inflammatory
confirmed
on
lipopolysaccharide-induced
lung
injury
mice.
Schaftoside
showed
good
safety
pharmacokinetic
property,
could
be
promising
drug
candidate
for
prevention
treatment
COVID-19.
ChatGPT
is
a
language
model
developed
by
OpenAI.
It
machine
learning
that
has
been
trained
on
large
dataset
of
human
language,
allowing
it
to
generate
human-like
text.
can
be
used
for
variety
natural
processing
tasks
such
as
translation,
text
summarization,
and
question
answering.
In
the
current
work
we
have
discussed
application
in
drug
discovery.
Frontiers in Microbiology,
Journal Year:
2023,
Volume and Issue:
14
Published: Oct. 2, 2023
Introduction
Fungus-derived
secondary
metabolites
are
fascinating
with
biomedical
potential
and
chemical
diversity.
Mining
endophytic
fungi
for
drug
candidates
is
an
ongoing
process
in
the
field
of
discovery
medicinal
chemistry.
Endophytic
fungal
symbionts
from
terrestrial
plants,
marine
flora,
fauna
tend
to
produce
interesting
types
importance
anticancer,
antiviral,
anti-tuberculosis
properties.
Methods
An
organic
ethyl
acetate
extract
Penicillium
verruculosum
sponge-derived
Spongia
officinalis
yielded
seven
different
which
purified
through
HPLC.
The
isolated
compounds
averufin
(1),
aspergilol-A
(2),
sulochrin
(3),
monomethyl
(4),
methyl
emodin
(5),
citreorosein
(6),
diorcinol
(7).
All
were
characterized
by
high-resolution
NMR
spectral
studies.
compounds',
such
as
antimicrobial,
anti-tuberculosis,
subjected
bioactivity
screening.
Results
Out
tested
compounds,
compound
(1)
exhibits
strong
anticancer
activity
toward
myeloid
leukemia.
HL60
cell
lines
have
IC
50
concentration
1.00μm,
nearly
significant
that
standard
taxol.
A
virtual
computational
molecular
docking
approach
antigens
revealed
binds
strongly
protein
target
alpha,
beta-tubulin
(1JFF),
a
−10.98
binding
score.
Consecutive
OSIRIS
Lipinski
ADME
pharmacokinetic
validation
has
good
properties
score,
solubility,
mutagenic
nature.
Furthermore,
(2)
first
report
on
strain.
Discussion
We
concluded
can
be
taken
further
preliminary
clinical
trials
like
animal
model
in-vivo
studies
pharmacodynamic
future
prospect
screening
validated
present
experimental
findings.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: July 14, 2023
Abstract
Exposure
to
the
spike
protein
or
receptor-binding
domain
(S-RBD)
of
SARS-CoV-2
significantly
influences
endothelial
cells
and
induces
pulmonary
vascular
endotheliopathy.
In
this
study,
angiotensin-converting
enzyme
2
humanized
inbred
(hACE2
Tg)
mice
cultured
were
used
investigate
how
protein/S-RBD
impacts
endothelium.
Results
show
that
S-RBD
leads
acute-to-prolonged
induction
intracellular
free
calcium
concentration
([Ca
2+
]
i
)
via
acute
activation
TRPV4,
prolonged
upregulation
mechanosensitive
channel
Piezo1
store-operated
(SOCC)
key
component
Orai1
in
human
arterial
(PAECs).
mechanism,
interacts
with
ACE2
induce
formation
clusters
involving
Orai1,
TRPC1,
facilitate
SOCC,
lead
elevated
apoptosis.
These
effects
are
blocked
by
Kobophenol
A,
which
inhibits
binding
between
ACE2,
chelator,
BAPTA-AM.
Blockade
SOCC
GsMTx4
effectively
protects
S-RBD-induced
microvascular
damage
hACE2
Tg
normalizing
[Ca
.
Comparing
prototypic
strain,
Omicron
variants
(BA.5.2
XBB)
less
severe
cell
Transcriptomic
analysis
indicates
confers
more
than
Delta
Lambda
S-RBD.
summary,
study
provides
compelling
evidence
could
persistent
triggering
through
Orai1.
Targeted
inhibition
ACE2-Piezo1/SOCC-[Ca
axis
proves
a
powerful
strategy
treat
diseases.
Antimicrobial Agents and Chemotherapy,
Journal Year:
2021,
Volume and Issue:
65(12)
Published: Sept. 20, 2021
Antivirals
are
urgently
needed
to
combat
the
global
SARS-CoV-2/COVID-19
pandemic,
supplement
existing
vaccine
efforts,
and
target
emerging
SARS-CoV-2
variants
of
concern.
Small
molecules
that
interfere
with
binding
viral
spike
receptor
domain
(RBD)
host
angiotensin-converting
enzyme
II
(ACE2)
may
be
effective
inhibitors
cell
entry.
Here,
we
screened
512
pure
compounds
derived
from
natural
products
using
a
high-throughput
RBD/ACE2
assay
identified
(-)-hopeaphenol,
resveratrol
tetramer,
in
addition
vatalbinoside
A
vaticanol
B,
as
potent
selective
For
example,
(-)-hopeaphenol
disrupted
50%
inhibitory
concentration
(IC50)
0.11
μM,
contrast
an
IC50
28.3
μM
against
unrelated
ligand/receptor
pair
PD-1/PD-L1
(selectivity
index,
257.3).
When
assessed
USA-WA1/2020
variant,
also
inhibited
entry
VSVΔG-GFP
reporter
pseudovirus
expressing
into
ACE2-expressing
Vero-E6
cells
vitro
replication
infectious
virus
cytopathic
effect
yield
reduction
assays
(50%
concentrations
[EC50s],
10.2
23.4
μM)
without
cytotoxicity
approaching
activities
control
antiviral
remdesivir
(EC50s,
1.0
7.3
μM).
Notably,
two
concern,
B.1.1.7/Alpha
B.1.351/Beta
both
spike-containing
similar
or
improved
over
variant.
These
results
identify
related
stilbenoid
analogues
across
multiple